Novartis joins Pfizer and J&J in putting on pricing brakes
Novartis is the latest big pharma company to pledge not to increase drug prices. But does this signal a shift in the industry?
Could big biotech succumb to the urge to merge?
With growth stalling at some of the industry's biggest biotechs is it time to take a leaf out of big pharma's M&A playbook?
Philips uses its intelligence for outcomes-based incomes
Philips prioritises artificial intelligence-based technologies as it seeks to grow its Connected Care and Health Informatics unit
Kickstarting ideas
Independent, data-driven daily news and analysis on pharma, biotech and medtech.